Follow-up after primary therapy for endometrial cancer: a systematic review (Q33237384)

24 July 2017

1 reference

title

Follow-up after primary therapy for endometrial cancer: a systematic review (English)

1 reference

24 July 2017

1 reference

1 reference

Michael Fung-Kee-Fung

1

1 reference

24 July 2017

Jason Dodge

2

1 reference

24 July 2017

Laurie Elit

3

1 reference

24 July 2017

Himu Lukka

4

1 reference

24 July 2017

Alex Chambers

5

1 reference

24 July 2017

Tom Oliver

6

1 reference

24 July 2017

Cancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group

7

1 reference

24 July 2017

language of work or name

English

0 references

publication date

23 March 2006

1 reference

24 July 2017

1 reference

24 July 2017

101

1 reference

24 July 2017

3

1 reference

24 July 2017

520-529

1 reference

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Value and cost evaluation of routine follow-up for patients with clinical stage I/II endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Is there any value in the long term follow up of women treated for endometrial cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

A critical evaluation of follow-up of women treated for endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Vaginal vault cytology in the routine follow-up of patients treated for endometrial carcinoma: is it useful?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Recurrence of endometrial carcinoma and the value of routine follow up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

An evaluation of routine follow-up of patients treated for endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Role of serial tumor markers in the surveillance for recurrence in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

CA 125 may not reflect disease status in patients with uterine serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

The role of routine follow-up after gynecological malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Risk-specific follow-up for endometrial carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.02.011

10.1016/J.YGYNO.2006.02.011

7 January 2021

Identifiers

DOI

1 reference

24 July 2017

1 reference